Filing Flows › Mesa Laboratories (MLAB) › Q4 FY26 › vs Q3 FY26
Mesa Laboratories (MLAB) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Mesa Laboratories's revenue fell $1.4M (-2%) from $65.1M in Q3 FY26 to $63.7M in Q4 FY26.
Mesa Laboratories, Q4 FY26: revenue $63.7M (+3% year over year), operating margin 4.3%, net loss $4.1M, operating cash flow $14.0M. The chart draws each line against Q3 FY26, the increases inside each band.
Margins
| Q4 FY26 | Q3 FY26 | Change | |
|---|---|---|---|
| Free cash flow margin | 21.3% | 27.7% | -6.4 pts |
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $63.7M | $65.1M | −$1.4M | -2% |
| Net loss | $4.1M | −$3.6M | $7.8M | — |
| Costs & expenses | $67.9M | $65.1M | $2.7M | +4% |
| Operating costs | $61.0M | $57.2M | $3.8M | +7% |
| Interest & other, net | $4.3M | $3.4M | $962K | +28% |
| Income tax | $2.5M | $966K | $1.6M | +163% |
| Cost of revenue | $21.5M | $23.3M | −$1.8M | -8% |
| Research & development | $5.2M | $5.0M | $218K | +4% |
| Sales & marketing | $10.1M | $10.0M | $92K | +0.9% |
| General & admin | $24.1M | $18.8M | $5.3M | +28% |
| Operating cash sources | $18.1M | $15.1M | $3.0M | +20% |
| Depreciation & amortization | $5.8M | $5.7M | $35K | +0.6% |
| Share-based compensation | $6.8M | $3.4M | $3.4M | +101% |
| Working capital & other | $5.6M | $6.0M | −$472K | -8% |
| Net loss absorbed | $4.1M | −$3.6M | $7.8M | — |
| Operating cash flow | $14.0M | $18.8M | −$4.8M | -26% |
| Free cash flow (OCF − capex) | $13.5M | $18.0M | −$4.5M | -25% |
| Capital expenditures | $417K | $732K | −$315K | -43% |
Questions
How much did Mesa Laboratories's revenue grow quarter over quarter in Q4 FY26?
Mesa Laboratories's revenue fell $1.4M (-2%) from $65.1M in Q3 FY26 to $63.7M in Q4 FY26.